Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic Center for Translational Science Activities, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Eur J Haematol. 2013 Sep;91(3):193-195. doi: 10.1111/ejh.12133. Epub 2013 Jul 22.
We previously reported an increased risk of monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of MGUS and multiple myeloma patients. Here, we examine whether primary cytogenetic categories of myeloma differ between patients with and without a family history of MGUS or myeloma. We studied 201 myeloma patients with available data on family history and molecular cytogenetic classification. Myeloma with trisomies was more common in probands who had an affected first-degree relative with MGUS or myeloma compared with those without a family history (46.9% vs. 33.5%, P = 0.125); however, the difference was not statistically significant. Additional studies on the cytogenetic types of myeloma associated with familial tendency are needed.
我们之前报道过,MGUS 和多发性骨髓瘤患者的一级亲属发生单克隆丙种球蛋白病的风险增加。在这里,我们研究了骨髓瘤的主要细胞遗传学分类是否在有和没有 MGUS 或骨髓瘤家族史的患者之间存在差异。我们研究了 201 名骨髓瘤患者,这些患者的家族史和分子细胞遗传学分类数据可用。与无家族史的患者相比,一级亲属有 MGUS 或骨髓瘤的先证者中存在三体的骨髓瘤更为常见(46.9%对 33.5%,P=0.125);然而,这种差异没有统计学意义。需要进一步研究与家族倾向相关的骨髓瘤细胞遗传学类型。